Suchergebnisse - "Kouroussis, C."

PubPharm (77)

11

Combination of Irinotecan (CPT-11) plus 5-Fluorouracil and Leucovorin (FOLFIRI Regimen) as First Line Treatment for Elderly Patients with Metastatic Colorectal Cancer: A Phase II Trial

enthalten in: Oncology | 2005

von Souglakos, J. | Pallis, A. | Kakolyris, S. | +6

12

Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin : a multicentre, randomised, phase II study

enthalten in: British journal of cancer | 2004

von Georgoulias, V. | Kouroussis, C. | Agelidou, A. | +11

13

Dose escalation study on oxaliplatin and capecitabine (Xeloda) in patients with advanced solid tumors

enthalten in: Oncology | 2004

von Kakolyris, S. | Souglakos, J. | Kouroussis, C. | +8

14

Dose Escalation Study on Oxaliplatin and Capecitabine (Xeloda) in Patients with Advanced Solid Tumors : Clinical Study

in: Oncology | 2004

von Kakolyris, S. | Souglakos, J. | Kouroussis, C. | +8

15

A Multicenter Phase II Study of the Combination of Irinotecan and Gemcitabine in Previously Treated Patients with Small-Cell Lung Cancer

enthalten in: Oncology | 2004

von Agelaki, S. | Syrigos, K. | Christophylakis, C. | +6

16

Dose Escalation Study on Oxaliplatin and Capecitabine (Xeloda) in Patients with Advanced Solid Tumors

enthalten in: Oncology | 2004

von Kakolyris, S. | Souglakos, J. | Kouroussis, C. | +6

17

Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a multicentre, randomised, phase II study

enthalten in: The British journal of cancer | 2004

von Georgoulias, V. | Kouroussis, C. | Agelidou, A. | +6

18

Clinical Studies - A Dose Escalation Study of Leucovorin (LV) and 48-hour Continuous Infusion of 5-Fluorouracil in Combination with Cyclophosphamide and Vinorelbine in Pretreated Patients with Metastatic Breast Cancer.

enthalten in: Anticancer research | 2004

von Kouroussis, C. | Kalbakis, K. | Androulakis, N. | +6

19

ZD1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer. Experience from a single center participating in a compassionate use program

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2003

von Pallis, A. | Mavroudis, D. | Androulakis, N. | +5

20

Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2003

von Xenidis, N. | Vlachonikolis, I. | Mavroudis, D. | +9